Apple's Simple Workaround for VirnetX Royalty Claims

Before you go, we thought you'd like these...
Before you go close icon

Apple's extremely simple workaround for VirnetX's networking patents reveal how easily the company's claims can be ignored. Add in a recent court victory by Cisco Systems over many of the same VirnetX claims, and the cracks in the patent trolling strategy start to show.

In this video, Fool contributor Anders Bylund explains why these developments are bad news for VirnetX.

There's no doubt that Apple is at the center of technology's largest revolution ever, and that longtime shareholders have been handsomely rewarded with over 1,000% gains. However, there is a debate raging as to whether Apple remains a buy. The Motley Fool's senior technology analyst and managing bureau chief, Eric Bleeker, is prepared to fill you in on both reasons to buy and reasons to sell Apple, and what opportunities are left for the company (and your portfolio) going forward. To get instant access to his latest thinking on Apple, simply click here now.

The article Apple's Simple Workaround for VirnetX Royalty Claims originally appeared on

Fool contributor Anders Bylund holds no position in any company mentioned. No, he's not shorting VirnetX, but his thumbs-down CAPScall on the stock is doing just fine. Check out Anders' bio and holdings or follow him on Twitter and Google+. The Motley Fool recommends Apple and Cisco Systems. The Motley Fool owns shares of Apple. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading